Enlivex Therapeutics
ENLV
ENLV
6 hedge funds and large institutions have $672K invested in Enlivex Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$323K |
| 2 |
Renaissance Technologies
New York
|
+$122K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3K |
Top Sellers
| 1 |
Jane Street
New York
|
-$632K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.57K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AIM
1
ARK Investment Management
St. Petersburg,
Florida
| $323K | +$323K | +38,536 | New |
|
|
2
Renaissance Technologies
New York
| $322K | +$122K | +14,600 | +61% |
|
|
3
UBS Group
Zurich,
Switzerland
| $24K | -$2.57K | -308 | -10% |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | +$3K | +418 | New |
|
|
5
Jane Street
New York
| – | -$632K | -23,655 | Closed |
|
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$3K | -125 | Closed |
|